[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3583887D1 - Ausruestung fuer die behandlung der osteoporose. - Google Patents

Ausruestung fuer die behandlung der osteoporose.

Info

Publication number
DE3583887D1
DE3583887D1 DE8585200650T DE3583887T DE3583887D1 DE 3583887 D1 DE3583887 D1 DE 3583887D1 DE 8585200650 T DE8585200650 T DE 8585200650T DE 3583887 T DE3583887 T DE 3583887T DE 3583887 D1 DE3583887 D1 DE 3583887D1
Authority
DE
Germany
Prior art keywords
regimen
daily doses
equipment
bone
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585200650T
Other languages
English (en)
Inventor
Vernon Albert Uchtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE3583887D1 publication Critical patent/DE3583887D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Debugging And Monitoring (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8585200650T 1984-04-30 1985-04-25 Ausruestung fuer die behandlung der osteoporose. Expired - Fee Related DE3583887D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60554084A 1984-04-30 1984-04-30
US68456084A 1984-12-21 1984-12-21

Publications (1)

Publication Number Publication Date
DE3583887D1 true DE3583887D1 (de) 1991-10-02

Family

ID=27084976

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8585200650T Expired - Fee Related DE3583887D1 (de) 1984-04-30 1985-04-25 Ausruestung fuer die behandlung der osteoporose.
DE3587956T Expired - Fee Related DE3587956T2 (de) 1984-04-30 1985-04-25 Ausrüstung für die Verwendung bei der Behandlung von Osteoporose.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3587956T Expired - Fee Related DE3587956T2 (de) 1984-04-30 1985-04-25 Ausrüstung für die Verwendung bei der Behandlung von Osteoporose.

Country Status (12)

Country Link
EP (2) EP0381296B1 (de)
JP (1) JPH0655675B2 (de)
AT (2) ATE114473T1 (de)
AU (1) AU584611B2 (de)
CA (1) CA1277233C (de)
DE (2) DE3583887D1 (de)
DK (1) DK173735B1 (de)
FI (1) FI851686L (de)
HK (1) HK46694A (de)
IE (1) IE66497B1 (de)
NZ (1) NZ211925A (de)
PH (1) PH22622A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
DE3514583A1 (de) * 1984-04-30 1985-10-31 The Procter & Gamble Co., Cincinnati, Ohio Verwendung eines zwei- oder mehrphasenmittels zur behandlung oder verhinderung von osteoporose
ES8802468A1 (es) * 1985-05-02 1988-07-16 Research Corp Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
JP3727332B2 (ja) * 1991-02-26 2005-12-14 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 骨粗鬆症の治療方法
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
CN1157565A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用骨活性膦酸盐和甲状旁腺激素治疗骨质疏松症的方法
FR2727629A1 (fr) * 1994-12-06 1996-06-07 Sanofi Sa Trousse pour cycle de traitement de l'osteoporose
EP0800397B1 (de) * 1994-12-28 2006-04-05 Gador S.A. Anabolische zubereitung für knochenmasse enthaltend olpadronat
IL120270A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
AR013994A1 (es) * 1998-10-30 2001-01-31 Gador Sa Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
NZ513827A (en) * 1999-03-05 2001-09-28 Procter & Gamble Methods of increasing bone volume using non-naturally-occurring FP selective agonists and antiresorptive compounds
HU228400B1 (en) 2000-06-20 2013-03-28 Novartis Ag The use of bisphosphonates for treatment of osteoporosis
EP1317247A1 (de) * 2000-09-13 2003-06-11 The Procter & Gamble Company Kosmetisches verfahren zur behandlung der haut und/oder haare
ES2930183T3 (es) 2006-12-29 2022-12-07 Ossifi Mab Llc Métodos para alterar el crecimiento óseo mediante la administración del antagonista o agonista de Sost o Wise

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
DE3514583A1 (de) * 1984-04-30 1985-10-31 The Procter & Gamble Co., Cincinnati, Ohio Verwendung eines zwei- oder mehrphasenmittels zur behandlung oder verhinderung von osteoporose
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
DK173735B1 (da) 2001-08-20
JPS6133117A (ja) 1986-02-17
ATE66608T1 (de) 1991-09-15
IE851084L (en) 1985-10-30
AU584611B2 (en) 1989-06-01
EP0381296B1 (de) 1994-11-30
NZ211925A (en) 1989-01-06
AU4176985A (en) 1985-11-07
IE66497B1 (en) 1996-01-10
HK46694A (en) 1994-05-20
PH22622A (en) 1988-10-28
ATE114473T1 (de) 1994-12-15
CA1277233C (en) 1990-12-04
FI851686A0 (fi) 1985-04-29
FI851686L (fi) 1985-10-31
EP0162510A1 (de) 1985-11-27
DK193585D0 (da) 1985-04-30
DE3587956T2 (de) 1995-05-24
DK193585A (da) 1985-10-31
EP0381296A1 (de) 1990-08-08
DE3587956D1 (de) 1995-01-12
EP0162510B1 (de) 1991-08-28
JPH0655675B2 (ja) 1994-07-27

Similar Documents

Publication Publication Date Title
DE3583887D1 (de) Ausruestung fuer die behandlung der osteoporose.
HUT43789A (en) Process for preparing synergic pharmaceuticals containing amantadine and selegiline
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
GR3002487T3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
DE3484416D1 (de) Intraalveolare vorrichtung zur verabreichung von wirkstoffen zum behandeln periodontaler krankheiten.
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
GR3004103T3 (de)
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
ATE149840T1 (de) Behandlung von leberkrebs
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
PH24445A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IE831131L (en) Use of a cholecalciferol derivative
ZA815094B (en) Novel peptide
ATE34079T1 (de) Verwendung von carbamidperoxid zur herstellung eines arzneimittels zur behandlung von akne vulgaris.
UA8596A1 (uk) Субстракт для вирощуваhhя істівhого гриба гливи звичайhої
AU106297S (en) A patient carrying frame
ES544317A0 (es) Mejoras introducidas en el objeto de la pat.principal n.542.339 por un procedimiento para preparar un depurador polimero organometalico macrorecticulado.
UA10995C2 (uk) Препарат "hейтрам" для лікуваhhя hеоhатальhих діарей у телят
HUT55226A (en) Process for producing pharmaceutical composition suitable for treating srural ulcer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee